Getting on target: Development of the novel, prozone-resistant, dual antibody rapid test (DART) for the LABScreen single antigen bead (SAB) assay.

[1]  J. Taupin,et al.  Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays , 2018, HLA.

[2]  N. Reinsmoen,et al.  Comprehensive assessment for serum treatment for single antigen test for detection of HLA antibodies. , 2017, Human immunology.

[3]  R. Bray,et al.  It's about time: The development and validation of a rapid optimized single antigen bead (ROB) assay protocol for LABScreen. , 2017, Human immunology.

[4]  N. Maillard,et al.  Relationship between Mean Fluorescence Intensity and C1q/C3d-fixing capacities of anti-HLA antibodies. , 2017, Human immunology.

[5]  N. K. Brown,et al.  EDTA is superior to DTT treatment for overcoming the prozone effect in HLA antibody testing , 2017, HLA.

[6]  P. Nickerson,et al.  Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor‐Specific Antibody , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  J. Friedewald,et al.  Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  X. Bossuyt,et al.  Antigen excess in modern immunoassays: to anticipate on the unexpected. , 2015, Autoimmunity reviews.

[9]  R. Bray,et al.  OR09: KEEP IT COOL. A NOVEL INHIBITOR COMPLEX EXCLUSION (ICE) PROTOCOL FOR LABSCREEN THAT PREVENTS THE “PROZONE” EFFECT , 2014 .

[10]  R. Bray,et al.  Solid‐phase assays for the detection of alloantibody against human leukocyte antigens: Panacea or Pandora? , 2014, International journal of immunogenetics.

[11]  S. Daburon,et al.  Deciphering Complement Interference in Anti–Human Leukocyte Antigen Antibody Detection With Flow Beads Assays , 2014, Transplantation.

[12]  R. Bray,et al.  HLA Antibody Detection With Solid Phase Assays: Great Expectations or Expectations Too Great? , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  S. Schaub,et al.  Determinants of C1q Binding in the Single Antigen Bead Assay , 2014, Transplantation.

[14]  M. Melcher,et al.  Center‐Defined Unacceptable HLA Antigens Facilitate Transplants for Sensitized Patients in a Multi‐Center Kidney Exchange Program , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  E. Schwaiger,et al.  Complement Component C3 Activation: The Leading Cause of the Prozone Phenomenon Affecting HLA Antibody Detection on Single-Antigen Beads , 2014, Transplantation.

[16]  R. Bray,et al.  Technical aspects of HLA antibody testing , 2013, Current opinion in organ transplantation.

[17]  C. Weinstock,et al.  The complement‐mediated prozone effect in the Luminex single‐antigen bead assay and its impact on HLA antibody determination in patient sera , 2013, International journal of immunogenetics.

[18]  P. Nickerson,et al.  Evolution and Clinical Pathologic Correlations of De Novo Donor‐Specific HLA Antibody Post Kidney Transplant , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  A. Ender,et al.  HLA Antibody Specification Using Single-Antigen Beads—A Technical Solution for the Prozone Effect , 2011, Transplantation.

[20]  Cecka Jm.  Current methodologies for detecting sensitization to HLA antigens. , 2011 .

[21]  J. Cecka,et al.  Calculated PRA: Initial Results Show Benefits for Sensitized Patients and a Reduction in Positive Crossmatches , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  R. Bray,et al.  The evolution and clinical impact of Human Leukocyte Antigen technology , 2010, Current opinion in nephrology and hypertension.

[23]  Dominique Charron,et al.  Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. , 2010, Journal of the American Society of Nephrology : JASN.

[24]  L. Sharples,et al.  Ten-Year Experience of Selective Omission of the Pretransplant Crossmatch Test in Deceased Donor Kidney Transplantation , 2010, Transplantation.

[25]  J. Steiger,et al.  Utility of the virtual crossmatch in solid organ transplantation , 2009, Current opinion in organ transplantation.

[26]  A. Zachary,et al.  Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution. , 2009, Human immunology.

[27]  A. Bingaman,et al.  A Virtual Crossmatch Protocol Significantly Increases Access of Highly Sensitized Patients to Deceased Donor Kidney Transplantation , 2008, Transplantation.

[28]  K. Kokko,et al.  Transplanting the Highly Sensitized Patient: The Emory Algorithm , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  P. Terasaki,et al.  Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities , 2003, Transplantation.

[30]  H. Gebel,et al.  Of Cells and Microparticles: Assets and Liabilities of HLA Antibody Detection. , 2018, Transplantation.

[31]  N. Maillard,et al.  From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays. , 2016, Clinical transplants.

[32]  J. Lunz,et al.  Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[33]  J. Bradley,et al.  Improved Luminex-based human leukocyte antigen-specific antibody screening using dithiothreitol-treated sera. , 2010, Human immunology.